Cowen & Co. analyst Phil Nadeau downgrades PhaseBio Pharmaceuticals (NASDAQ:PHAS) from Outperform to Market Perform.
MGM Resorts Could Lose Out On Casino Licenses In New York City Due To Bookie Scandal: Report
Chances of MGM Resorts International (NYSE: MGM) to win two of the three coveted full-scale casino licenses in New York city has reportedly become complicated after an alleged bookmaking scandal that's unfolding in Las Vegas.